Ipamorelin: Selective GH Regulation
Endocrinology

Ipamorelin: Selective GH Regulation

Abstract: Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH2) is a potent ghrelin mimetic. We analyze its high selectivity for the GHS-R1a receptor and its minimal impact on ACTH and cortisol levels in laboratory models.

The Specificity of Secretagogues

Ipamorelin is a synthetic pentapeptide that acts as a potent and selective growth hormone secretagogue. In research settings, it is particularly noted for its ability to mimic the action of ghrelin, binding to the ghrelin/growth hormone secretagogue receptor (GHS-R1a).

Key Research Observations

One of the most significant aspects of Ipamorelin in laboratory studies is its selectivity. Unlike earlier secretagogues, it has been observed to stimulate GH release while having minimal to no effect on the secretion of cortisol, prolactin, or aldosterone.

Research Applications

Researchers utilize Ipamorelin to study the mechanisms of growth hormone pulsatility and its downstream effects on metabolic regulation, bone density, and muscle tissue maintenance without the confounding variables of broad hormonal stimulation.

Scientific References:

[1] Raun, K., et al. (1998). "Ipamorelin, the first selective growth hormone secretagogue." European Journal of Endocrinology.

[2] Johansen, P. B., et al. (1999). "Ipamorelin, a new growth-hormone-releasing peptide, induces growth of whole body and of several tissues in rats." Endocrinology.